Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Thomas Systchenko, n/a
CHU de Poitiers, France
Poster(s):
(P-1967)
Characteristics of the first immunocompromised patients to receive Sipavibart as an early access treatment for COVID-19 pre-exposure prophylaxis in France
Saturday, October 19, 2024
12:15 PM – 1:30 PM
US PT